castor oil

Botanicalexperimental

Castor oil is a vegetable oil pressed from castor beans, the seeds of the plant Ricinus communis. The seeds are 40 to 60 percent oil. It is a colourless or pale yellow liquid with a distinct taste and odor. Its boiling point is 313 °C (595 °F) and its density is 0.961 g/cm3. It includes a mixture of triglycerides in which about 90 percent of fatty acids are ricinoleates. Oleic acid and linoleic acid are the other significant components. — Wikipedia

Clinical trial activity

19 trials · 19 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
7
Phase 3
2
Phase 4
1

Earliest trial started Feb 1, 2006 (NCT00244738)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • castor oil
  • castor oil
  • castor oil
  • castor oil
  • castor oil
  • castor oil, aromatic
  • oleum ricini

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05723900N/ASep 15, 2022Tanta University
NCT05013151N/AAug 24, 2021Clalit Health Services, Technion University
NCT06841939N/AMar 5, 2021Federal Teaching Hospital Abakaliki
NCT03958981N/AJun 15, 2019Cairo University
NCT04807543Phase 2Jan 10, 2018Ain Shams University
NCT02615912N/ANov 30, 2015Kimberly Clark, RCTS, Inc.
NCT02004067Phase 4Jan 1, 2013Allergan, University of Sao Paulo
NCT01119963Phase 2/Phase 3 (Phase 3)Oct 1, 2011Obstetrix Medical Group
NCT01433159Phase 2Sep 1, 2011Healthpoint
NCT01273428Phase 2Dec 3, 2010Healthpoint
NCT01050647Phase 1/Phase 2 (Phase 2)Feb 1, 2010Stanford University
NCT01206270Phase 2/Phase 3 (Phase 3)Jun 1, 2009University of Roma La Sapienza
NCT00714519Phase 2Jul 1, 2008Healthpoint
NCT00713349Phase 2Jun 1, 2008Healthpoint, Wake Forest University
NCT01732744N/AMar 31, 2008Fundação de Amparo à Pesquisa do Estado de São Paulo, University of Sao Paulo
NCT00645164Phase 1Mar 1, 2008Eurofins, Healthpoint
NCT00644917Phase 1Feb 1, 2008Healthpoint
NCT00141908Phase 2Oct 1, 2006American University of Beirut
NCT00244738N/AFeb 1, 2006Hebrew University
Showing 19 of 19 trials
Page 1 / 1

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
HealthpointFor profit6622008
University of Sao PauloAcademic/Hospital2222008
Ain Shams UniversityAcademic/Hospital1112018
AllerganFor profit1012013
American University of BeirutAcademic/Hospital1112006
Cairo UniversityAcademic/Hospital1112019
Clalit Health ServicesAcademic/Hospital1012021
EurofinsFor profit1012008
Federal Teaching Hospital AbakalikiAcademic/Hospital1112021
Fundação de Amparo à Pesquisa do Estado de São PauloAcademic/Hospital1012008
Hebrew UniversityAcademic/Hospital1112006
Kimberly ClarkFor profit1112015
Obstetrix Medical GroupAcademic/Hospital1112011
RCTS, Inc.For profit1012015
Stanford UniversityAcademic/Hospital1112010
Tanta UniversityAcademic/Hospital1112022
Technion UniversityAcademic/Hospital1112021
University of Roma La SapienzaAcademic/Hospital1112009
Wake Forest UniversityAcademic/Hospital1012008
19 organizations
Page 1 / 1